Contribution of the carboxy-terminal domain of lipoprotein lipase to interaction with heparin and lipoproteins

A Lookene, MS Nielsen, J Gliemann… - … and Biophysical Research …, 2000 - Elsevier
A Lookene, MS Nielsen, J Gliemann, G Olivecrona
Biochemical and Biophysical Research Communications, 2000Elsevier
The C-terminal domain of lipoprotein lipase (LPL) is involved in several important
interactions. To assess its contribution to the binding ability of full-length LPL we have
determined kinetic constants using biosensor technique. The affinity of the C-terminal
domain for heparin was about 500-fold lower than that of full-length LPL (Kd= 1.3 μM
compared to 3.1 nM). Replacement of Lys403, Arg405 and Lys407 by Ala abolished the
heparin affinity, whereas replacement of Arg420 and Lys422 had little effect. The C-terminal …
The C-terminal domain of lipoprotein lipase (LPL) is involved in several important interactions. To assess its contribution to the binding ability of full-length LPL we have determined kinetic constants using biosensor technique. The affinity of the C-terminal domain for heparin was about 500-fold lower than that of full-length LPL (Kd = 1.3 μM compared to 3.1 nM). Replacement of Lys403, Arg405 and Lys407 by Ala abolished the heparin affinity, whereas replacement of Arg420 and Lys422 had little effect. The C-terminal domain increased binding of chylomicrons and VLDL to immobilized heparin relatively well, but was less than 10% efficient in binding of LDL compared to full-length LPL. Deletion of residues 390–393 (WSDW) did not change the affinity to heparin and only slightly decreased the affinity to lipoproteins. We conclude that the C-terminal folding domain contributes only moderately to the heparin affinity of full-length LPL, whereas the domain appears important for tethering triglyceride-rich lipoproteins to heparin-bound LPL.
Elsevier